| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals Inc (IRWD) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. IRWD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $7.09M | - | |
| VP | 658.0K | $2.46M | - | |
| Other | 500.5K | $1.87M | - | |
| Other | 416.6K | $1.56M | - | |
| Other | 350.4K | $1.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2016 | Olanoff Lawrence S | Director | Sell | 2,200 | $11.11 | $24,442.00 | -16.6% | |
| Feb 24, 2016 | McCourt Thomas A66 | Chief Commercial Officer | Sell | 1,600 | $8.50 | $13,600.00 | -5.5% | |
| Feb 24, 2016 | Graney Thomas | Chief Financial Officer | Sell | 563 | $8.50 | $4,785.50 | -9.9% | |
| Feb 24, 2016 | Consylman Gina | Chief Accounting Officer | Sell | 420 | $8.50 | $3,570.00 | -6.2% | |
| Feb 24, 2016 | Gilbert Halley E | Chief Legal Officer | Sell | 2,778 | $8.50 | $23,613.00 | -7.1% | |
| Feb 24, 2016 | Currie Mark G53 | Chief Scientific Officer | Sale+OE | 152,154 | $8.53 | $1,297,809.00 | -27.6% | |
| Feb 24, 2016 | Owens Edward P | Director | Buy | 10,000 | $8.32 | $83,200.00 | +7.5% | |
| Dec 15, 2015 | Hecht Peter M | Chief Executive Officer | Sale+OE | 73,418 | $11.07 | $812,737.26 | -100% | |
| Dec 7, 2015 | Olanoff Lawrence S | Director | Sell | 2,200 | $11.77 | $25,894.00 | -14.3% | |
| Sep 4, 2015 | Olanoff Lawrence S | Director | Sell | 3,725 | $10.97 | $40,863.25 | -19.4% |